PATENT CLAIM ANALYSIS

Application Number: 15781213
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "620000"]

Abstract:
A pharmaceutical composition for treating leukemia, mainly made of the following raw materials by weight percentage: 2 to 8 percent of realgar, 25 to 42 percent of indigo naturalis, 50 to 60 percent of salvia miltiorrhiza, and 6 to 10 percent of heterophylla. The present disclosure improves the preparation method of salvia miltiorrhiza, reduces the amount of the adding water, the number of decocting times and the decocting time. Tanshiuone IIA extraction rate reaches 75%. The pharmaceutical composition of the present disclosure can treat leukemia, the complete remission rate reaches 92.9%, the curative effect is obviously improved, and the toxic side effects are greatly reduced.

Claim (Index 10):
The method according to  claim 7 , wherein the pharmaceutical dosage form is capsules; the concentrate is a clear paste with a relative density of 1.15 to 1.20 measured at a temperature of 50\u00b0 C.; and then the clear paste is mixed with the mixture, granulated, dried, sized, compressed, and filled into capsules.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.65753
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14903684', '12706522', '15839992', '15564944', '15634489']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7251743404006707
- 35 USC 102 Novelty (BERT): 0.5073873185399769
- Combined Prediction Score: 0.7033956382146014
- Mean Citation Score: 210.017684
- Max Citation Score: 221.63336
- Similarity Product: 134.16055347632408

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test